New grants for MazeBio, Akteon, Larmor and HelixScreen
— Four promising startup projects: MazeBio, Akteon, Larmor and HelixScreen are supported by the EPFL Startup Launchpad and taking the next steps towards bringing their technologies to market. MazeBio and Akteon have each received a CHF 30,000 Ignition Grant, while Larmor and HelixScreen have each been awarded a CHF 100,000 Innogrant.
Spanning AI-powered drug discovery, compact flow cytometry, fusion energy and personalised cancer treatment, the four projects are addressing challenges across healthcare, biotechnology and energy, turning cutting-edge EPFL research into technologies with the potential for real-world impact.